Guselkumab efficacy and safety through 5 years among psoriasis patients with and without metabolic syndrome at baseline: Results from VOYAGE 1 and VOYAGE 2

被引：0
|
作者：
Merola, Joseph F. [1 ]
Thaci, Diamant [2 ]
Choi, Olivia [3 ]
Chan, Daphne [3 ]
Yang, Ya-Wen [4 ]
Miller, Megan [5 ]
You, Yin [5 ]
Li, Shu [5 ]
Blauvelt, Andrew [6 ]
Puig, Luis [7 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[2] Univ Lubeck, Lubeck, Germany
[3] Janssen Sci Affairs LLC, Horsham, PA USA
[4] Janssen Pharmaceut Companies Johnson & Johnson, Immunol Global Med Affairs, Horsham, PA USA
[5] Janssen Res & Dev LLC, Spring House, PA USA
[6] Oregon Med Res Ctr, Portland, OR USA
[7] Autonomous Univ Barcelona, Hosp Santa Creu & St Pau, Barcelona, Spain
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2022年 / 87卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
33055
引用
收藏
页码：AB170 / AB170
页数：1
相关论文
共 50 条
  • [1] Safety of guselkumab in patients with plaque psoriasis through 2 years: a pooled analysis from VOYAGE 1 and VOYAGE 2
    Reich, K.
    Papp, K.
    Armstrong, A. W.
    Wasfi, Y.
    Jiang, G.
    Shen, Y-K.
    Randazzo, B.
    Song, M.
    Kimball, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E297 - E297
  • [2] Immunogenicity of Guselkumab among psoriasis patients in VOYAGE 1 and VOYAGE 2
    Reich, K.
    Armstrong, A. W.
    Zhu, Y.
    Miller, M.
    You, Y.
    Shen, Y. -K.
    Yang, Y. W.
    Foley, P.
    Griffiths, C. E. M.
    Strober, B.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 42 - 42
  • [3] Safety of guselkumab in patients with psoriasis with a history of malignancy: 5-year results from the VOYAGE 1 and VOYAGE 2 trials
    Blauvelt, Andrew
    Thaci, Diamant
    Papp, Kim A.
    Ho, Vincent
    Ghoreschi, Kamran
    Kim, Byung Soo
    Miller, Megan
    Shen, Yaung-Kaung
    You, Yin
    Chan, Daphne
    Yu, Jenny
    Yang, Ya-Wen
    Lebwohl, Mark G.
    Gottlieb, Alice B.
    Crowley, Jeffrey
    Foley, Peter
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (01) : 132 - 134
  • [4] FOUR-YEAR EFFICACY AND SAFETY OF GUSELKUMAB IN PSORIASIS PATIENTS WITH AND WITHOUT PSORIATIC ARTHRITIS: A POOLED ANALYSIS FROM VOYAGE 1 AND VOYAGE 2
    Reich, K.
    Dutz, J.
    Foley, P.
    Thaci, D.
    Vender, R.
    Song, M.
    Miller, M.
    You, Y.
    Li, S.
    Shen, Y. K.
    Armstrong, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1673 - 1673
  • [5] Long-term efficacy and safety of guselkumab in psoriasis patients with and without psoriatic arthritis: A pooled analysis from VOYAGE 1 and VOYAGE 2
    Kimball, A. B.
    Foley, P.
    Thaci, D.
    Vender, R.
    Song, M.
    Li, S.
    Fakharzadeh, S.
    Shen, Y. -K.
    Armstrong, A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB233 - AB233
  • [6] Four-Year Efficacy and Safety of Guselkumab in Psoriasis Patients with and Without Psoriatic Arthritis: A Pooled Analysis from VOYAGE 1 and VOYAGE 2
    Reich, Kristian
    Dutz, Jan
    Foley, Peter
    Thaci, Diamant
    Vender, Ron
    Song, Michael
    Miller, Megan
    Yu, Yin
    Li, Shu
    Shen, Yaung-Kaung
    Armstrong, April W.
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] Efficacy responses across subgroups of patients with moderate to severe plaque psoriasis treated with Guselkumab: Results from VOYAGE 1 through 5 years
    Thaci, D.
    Foley, P.
    Puig, L.
    Merola, J. F.
    Miller, M.
    You, Y.
    Shen, Y. -K.
    Yang, Y. -W.
    Blauvelt, A.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 41 - 42
  • [8] Long-term safety of guselkumab: Results from the VOYAGE 1 and VOYAGE 2 trials with up to 5 years of treatment
    Blauvelt, Andrew
    Gordon, Kenneth B.
    Griffiths, Christopher E. M.
    Papp, Kim A.
    Foley, Peter
    Song, Michael
    Miller, Megan
    Shen, Yaung-Kaung
    You, Yin
    Ramachandran, Paraneedharan
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB174 - AB174
  • [9] Malignancy rates through 5 years of follow-up in patients with moderate-to-severe psoriasis treated with guselkumab: Pooled results from the VOYAGE 1 and VOYAGE 2 trials
    Blauvelt, Andrew
    Lebwohl, Mark
    Langley, Richard G.
    Rowland, Katelyn
    Yang, Ya-Wen
    Chan, Daphne
    Miller, Megan
    You, Yin
    Yu, Jenny
    Thaci, Diamant
    Foley, Peter
    Papp, Kim A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (02) : 274 - 282
  • [10] EFFICACY RESPONSES ACROSS DISEASE SEVERITY AND TREATMENT HISTORY SUBGROUPS OF PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS TREATED WITH GUSELKUMAB: POOLED RESULTS FROM VOYAGE-1 AND VOYAGE-2 THROUGH 5 YEARS
    Gordon, K.
    Merola, J. F.
    Foley, P.
    Choi, O.
    Chan, D.
    Miller, M.
    You, Y.
    Shen, Y. K.
    Yang, Y. W.
    Blauvelt, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1842 - 1842
12345